ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 47 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,580 | -59.8% | 91,807 | -47.8% | 0.00% | – |
| Q2 2023 | $170,775 | +48278.2% | 175,875 | -56.4% | 0.00% | – |
| Q1 2023 | $353 | -0.3% | 403,370 | +8.6% | 0.00% | – |
| Q4 2022 | $354 | -99.9% | 371,319 | +11.8% | 0.00% | – |
| Q3 2022 | $365,000 | -35.1% | 332,131 | -28.5% | 0.00% | – |
| Q2 2022 | $562,000 | +104.4% | 464,409 | +1907.6% | 0.00% | – |
| Q4 2021 | $275,000 | -74.7% | 23,133 | -66.9% | 0.00% | -100.0% |
| Q3 2021 | $1,085,000 | +46.4% | 69,943 | +114.8% | 0.00% | 0.0% |
| Q1 2021 | $741,000 | – | 32,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |